<DOC>
	<DOCNO>NCT00978965</DOCNO>
	<brief_summary>This study design define group patient ( among patient heart kidney graft glomerular disease nephrotic range proteinuria ) would either profit therapy mycophenolate-mofetil ( MMF ) need high conventional dose respond . Mainly 2 possible explanation inter-patient difference responsiveness MMF therapy : 1 . Based mutation ( study single nucleotide polymorphisms-SNPs- ) inosine monophosphate dehydrogenase 2 ( IMPDH 2 ) transcript target enzyme mycophenolic acid ( MPA ) pathway , MMF exert effect . 2 . Based high enzyme activity IMPDH 2 high MMF dose conventional regimen need . To study significance possible explanation 4 objective study : Objective 1 : Since data SNPs functional relevance IMPDH 2 transcript , first sequence 14 exon gene entirety 100 gender age match healthy individual . Objective 2 : The functional relevance detect SNP test vitro lymphocyte proliferation assay use various MPA concentration . Objective 3 : These functionally relevant SNPs search patient kidney graft retrospective well prospective manner . Objective 4 : Parallel genotyping experiment , IMPDH 2 activity MPA plasma level measure patient recruit study prospectively . An association SNPs various IMPDH 2 activity / MPA plasma level MMF responsiveness examine .</brief_summary>
	<brief_title>Identification Patients With High Probability Poorly Responding Therapy With Mycophenolic Acid Prodrugs</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>patient de novo kidney graft age &gt; 18 &lt; 75 pregnancy panel antigens reactivity &gt; 40 %</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>kidney transplantation</keyword>
	<keyword>immunosuppression</keyword>
	<keyword>single nucleotide polymorphism</keyword>
	<keyword>IMPDH</keyword>
</DOC>